DBT secretary launches 5th edition of C-CAMP’s National Bio Entrepreneurship Competition
The competition now in its fifth year is a nationwide search for exceptional ideas in the life sciences domain with potential for both social impact and commercial success
Aurobindo Pharma on Thursday said it will acquire a 51% stake in generic veterinary pharma firm Cronus Pharma Specialties India for Rs 420 crore ($56 million)
The deal is expected to give Aurobindo a foothold in the $48 billion global animal health market.
.jpeg)
